Brought to you by 
Qiagen buys Genaco for $22mm in cash plus earnouts
Nov 2006
Executive Summary
Qiagen NV has acquired fellow molecular diagnostics company Genaco Biomedical Products for $22mm in cash and up to $18mm in earn-outs contingent upon receiving grants and funding. Qiagen also issued Genaco's founder 125k shares of restricted stock.
Deal Industry
- Biotechnology
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
-
Research, Analytical Equipment & Supplies
- PCR & Amplification Tools
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Cash
- Payment Includes Stock
- Intra-Biotech Deal
- Includes Earnout
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
Advertisement
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Qiagen buys Genaco for $22mm in cash plus earnouts
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice